Attention Investors: Take Action Now with Robbins Geller Rudman & Dowd LLP for Outlook Therapeutics Inc. Losses!
The Impact of the OTLK Investor Notice Investor Alert: Are You Affected? If you are a purchaser or acquirer of Outlook Therapeutics, Inc. (NASDAQ: OTLK) securities between December 29, 2022 and August 29, 2023, you may be impacted by the recent announcement from Robbins Geller Rudman & Dowd LLP. Investors with substantial losses during this…